Gelteq is trading at $0.49, up 13.85% in pre-market, with the catalyst unclear.

  • The pre-market rise follows an unexplained after-hours jump; no confirmed company catalyst has been identified.
  • Gelteq’s latest regular-session close was $0.43 on October 19, after a week of declines. A market listing showed no Gelteq headlines for October 20, and the supplied biotech-sector trend was down, not aligned with this rise. Available evidence does not establish a reason pending further news.